Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $230.8500 (4.93%) ($211.0000 - $249.7500) on Tue. May. 25, 2010. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.97% (three month average) | RSI | 36 | Latest Price | $230.8500(4.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -4.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -9.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -2.985% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.985% (StdDev 5.97%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
Resistance Level | $287.65 | 5 Day Moving Average | $244.6(-5.62%) | 10 Day Moving Average | $262.88(-12.18%) | 20 Day Moving Average | $287.65(-19.75%) | To recent high | -61.5% | To recent low | 4.9% | Market Cap | $4.547b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |